Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial

Deng, Yanhong; Chi, Pan; Lan, Ping; Wang, Lei; Chen, Weiqing; Cui, Long; Daoda, Chen; Cao, Jie; Wei, Hongbo; Peng, Xiang; Huang, Zong-hai; Cai, Guanfu; Zhao, Ren; Huang, Zhongcheng; Xu, Lin; Zhou, Hongfeng; Wei, Yisheng; Zhang, Hao; Zheng, Jian; Huang, Yan; Zhou, Zhiyang; Cai, Yue; Kang, Liang; Huang, Meijin; Wu, Xiaojian; Peng, Junsheng; Ren, Donglin; Wang, Jianping

doi:10.1200/jco.18.02309

Public

Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial

Published in Journal of Clinical Oncology • Sep 26, 2019

Authors:

Yanhong Deng

Pan Chi

Ping Lan

Abstract

PURPOSE In the multicenter, open-label, phase III FOWARC trial, modified infusional fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus radiotherapy resulted in a higher pathologic complete response rate than fluorouracil plus radiotherapy in Chinese patients with locally advanced rectal cance...

Subject

Medicine

Fluorouracil

Oxaliplatin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!